Cuproptosis-related gene DLAT serves as a prognostic biomarker for immunotherapy in clear cell renal cell carcinoma: multi-database and experimental verification
Aging · 2023
DOI: 10.18632/aging.205181 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging, 2023. Verfasst von Shuaishuai Huang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory, Ningbo Urology and Nephrology Hospital, Ningbo, China. Hauptthemen laut MEDLINE: Carcinoma, Carcinoma, Renal Cell, Kidney Neoplasms, Apoptosis. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
OBJECTIVE: Renal clear cell carcinoma (ccRCC) is the most common type of renal cancer. Here we aim to explore the prognosis and immunotherapeutic value of copper death-related gene Dihydrolipoamide S-acetyltransferase (DLAT) in ccRCC. METHODS: The mRNA and protein expressions and methylation level of DLAT, as well as the relation of DLAT to survival prognosis, clinical characteristics, biological function, and immune microenvironment and responses in patients with ccRCC were evaluated using multiple databases. In addition, 75 paired ccRCC tissue samples and 3 kinds of cell lines were tested for experimental validation. RESULTS: Bioinformatics analysis of multiple databases, qRT-PCR, and western blot verified that DLAT expression in ccRCC was lower than that in paracancerous tissues. Patients with low expression of DLAT had a lower survival rate, worse clinical prognosis, stronger immune cell infiltration and expression of immunosuppressive points, and higher tumor immune dysfunction and exclusion (TIDE) scores. CONCLUSIONS: DLAT was identified as an independent prognostic factor in ccRCC and was closely related to the prognosis and immune responses of patients with ccRCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory, Ningbo Urology and Nephrology Hospital, Ningbo, China.
- Department of Emergency, Ningbo Urology and Nephrology Hospital, Ningbo, China.
- Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Ultrasound, Ningbo Urology and Nephrology Hospital, Ningbo, China.
Zitieren
APA
Huang, S., Cai, C., Zhou, K., Wang, X., Wang, X., Cen, D., & Weng, G. (2023). Cuproptosis-related gene DLAT serves as a prognostic biomarker for immunotherapy in clear cell renal cell carcinoma: multi-database and experimental verification. Aging. https://doi.org/10.18632/aging.205181
Vancouver
Huang S, Cai C, Zhou K, Wang X, Wang X, Cen D, et al. Cuproptosis-related gene DLAT serves as a prognostic biomarker for immunotherapy in clear cell renal cell carcinoma: multi-database and experimental verification. Aging. 2023. doi:10.18632/aging.205181
BibTeX
@article{Huang2023,
author = {Huang, Shuaishuai and Cai, Congbo and Zhou, Kena and Wang, Xue and Wang, Xue and Cen, Dong and Weng, Guobin},
title = {Cuproptosis-related gene DLAT serves as a prognostic biomarker for immunotherapy in clear cell renal cell carcinoma: multi-database and experimental verification},
journal = {Aging},
year = {2023},
doi = {10.18632/aging.205181}
}
EUVIMED